YUCAIPA, Calif., Aug. 16, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), an emerging medical device manufacturer developing innovative proprietary solutions for the $8 billion respiratory market, today announced that its partner, KGMA, successfully demonstrated its product at the 13th Annual Force Health Protection Conference in Phoenix, Arizona.
Approximately 2,200 individuals attended the conference, where KGMA made numerous presentations of Ingen's Oxyview product line to military doctors, nurses and other military medical professionals. The product was very well received and the medical personnel present could readily comprehend the value and benefits that the technology provided for both patients and medical device providers.
Contact and ordering information was provided to a large number of military representatives who expressed interest in Ingens' products, including U.S. Army institutions in Georgia, Washington D.C., Michigan, New Mexico, Hawaii and others. Additionally, KGMA received inquiries related to Ingen's listing on the GSA schedule, which also shows positive signs of interest.
"Ingen continues to rapidly scale its sales efforts across a number of markets, while offering top-quality products to America's Armed Forces," said CEO Scott Sand. "Oxyview Flow Meters greatly improve quality-of-care at an unbeatable value, as we continue to target $1.4 million in revenue available through various government facilities for the remainder of the year."
Investors can review our current fact sheet at the following link:
http://www.ingen-tech.com/PDFbin/FactSheet.pdf
Company Websites:
http://www.ingen-tech.com
http://www.smartnasalcannula.com/
http://www.ingenpulseoximeter.com/
About Ingen:
Ingen is an ISO Certified medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the US, and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing US and Foreign Patents and a successful registration with the Food & Drug Administration. The company is establishing domestic and global distribution with manufacture representative organizations, and OEM partners. In 2009 the SMART Nasal Cannula using Oxyview Technology was introduced as the world's first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010 the company introduced its new INGEN Pulse Oximeter. The Oxyview product line is available to the home care markets, commercial medical markets, aviation, automotive, and government sources. The company is licensed with the Department of Health and Human Services, and manufactures its products in the State of California. With approximately 32 million US patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements:
This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.